AIM ImmunoTech
AIM • AMEX
AIM ImmunoTech is a biotechnology company in the healthcare sector trading on AMEX, led by CEO Thomas K. Equels, with a market cap of $4.2M.
Market Cap$4.2M
Employees28.0
CEOThomas K. Equels
CountryUnited States of America
Healthcare
Biotechnology
Financials
AIM ImmunoTech FAQ
Common questions about AIM ImmunoTech
AIM ImmunoTech has approximately 28 employees.